Demographic & clinical data |
Patient |
1 |
2 |
3 |
|
Age at diagnosis (years) |
2 |
43 |
10 |
|
|
Sex |
Male |
Male |
Male |
|
|
Seizure/epilepsy |
No |
Yes |
Yes |
|
|
Seizure/epilepsy started (years) |
|
8 |
10 |
|
|
Surgery |
No (biopsy‐proven) |
Yes |
Yes |
|
|
Chemotherapy |
Yes |
No |
No |
|
|
Recurrence, period (from surgery) |
|
No |
No |
|
|
Patient status |
Survive |
Survive |
Survive |
|
|
Follow up duration (month) |
39 |
72 |
38 |
|
Imaging data |
Size (mm: Anteroposterior × transverse × craniocaudal) |
38 × 40 × 41 |
8 × 9 × 10 |
24 × 28 × 21 |
|
|
Laterality |
Middle |
Left |
Left |
|
|
Tumor site |
Pons, Medulla |
Frontal lobe |
Occipital lobe |
|
|
Tumor margin |
Well |
Well |
Well |
|
|
Involvement of both cortex and subcortex |
|
Yes |
Yes |
|
|
Massive surrounding edema (≥tumor size) |
No |
No |
No |
|
|
Morphology |
Solid |
Cystoid |
Solid |
|
|
MRI signal intensity |
T2‐weighted image (compared with cortex) |
High |
High |
High |
|
|
Fluid‐attenuated inversion recovery image (compared with cortex) |
High |
High & Low |
High |
|
|
T1‐weighted image (compared with cortex) |
Low |
High & Low |
Low |
|
Apparent diffusion coefficient (10–3mm2/s) |
1.6 |
1.04 |
1.34 |
|
|
Stalk‐like sign |
No |
Yes |
Yes |
|
|
Atrophy of the brain parenchyma near the tumor site |
No |
Yes |
No |
|
|
Contrast enhancement |
No |
No |
Nodular |
|